Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metabolic Cofactors and Hydroxychloroquine for COVID-19
NCT04573153Phase 3Terminated
- Sponsor
- ScandiBio Therapeutics
- Start
- Sep 2020
- Primary completion
- May 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine, l-carnitine tartrate, nicotinamide riboside, serine in coronavirus disease 2019 (COVID-19), sponsored by ScandiBio Therapeutics. Started Sep 2020; status: terminated.
02
Drugs
acetylcysteinel-carnitine tartratenicotinamide ribosideserine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04573153.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04573153.